UK markets closed

GlaxoSmithKline plc (GLAXF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
18.00+0.74 (+4.29%)
As of 10:02AM EST. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2023)Next year (2024)
No. of analysts411717
Avg. Estimate0.40.451.931.97
Low estimate0.380.451.661.65
High estimate0.450.452.042.08
Year ago EPS0.320.471.721.93
Revenue estimateCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2023)Next year (2024)
No. of analysts411717
Avg. Estimate9.6B8.99B37.7B39.7B
Low estimate9.48B8.99B36.8B38.5B
High estimate9.71B8.99B38.32B40.82B
Year ago sales9.06B8.85B36.03B37.7B
Sales growth (year/est)6.00%1.60%4.60%5.30%
Earnings history30/12/202230/03/202329/06/202329/09/2023
Est. EPS0.260.430.430.6
Actual EPS0.320.470.470.64
Difference0.060.040.040.04
Surprise %23.10%9.30%9.30%6.70%
EPS trendCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2023)Next year (2024)
Current estimate0.40.451.931.97
7 days ago0.40.441.91.96
30 days ago0.40.431.821.89
60 days ago0.390.431.811.87
90 days ago0.420.431.871.92
EPS revisionsCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/A1
Up last 30 days3N/A76
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/A12
Growth estimatesGLAXFIndustrySector(s)S&P 500
Current qtr.25.00%N/AN/AN/A
Next qtr.-4.30%N/AN/AN/A
Current year12.20%N/AN/AN/A
Next year2.10%N/AN/AN/A
Next 5 years (per annum)0.11%N/AN/AN/A
Past 5 years (per annum)-0.37%N/AN/AN/A